european network for adrenal tumors

 

clinical trials

EURINE-ACT - EURINE-ACT is an international prospective study that examines the diagnostic and prognostic value of urine steroidobolomics in patients with adrenocortical tumours.

ADIUVO - The ADIUVO study is a prospective, randomized, open-label, controlled, international, phase III trial for patients with ACC after radical resection.

FIRM-ACT (First International Randomized trial in locally advanced and Metastatic Adrenocortical Carcinoma Treatment) Recruitment closed October 2009, first results will be expected end of 2010.

PMT3is an international multicenter prospective study of biomarkers for prediction of malignancy and hereditary pheochromocytoma and paragliomas (PPGLs).
  © ENS@T - European Network for the Study of Adrenal Tumors 2002 - 2012
Powered by Wild Apricot Membership Software